• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines N-alkylpiperazines

Introduction to 1-(2-methylpropyl)piperazine hydrochloride (CAS No. 510725-53-8)

1-(2-methylpropyl)piperazine hydrochloride, with the chemical formula C?H??N·HCl, is a derivative of piperazine that has garnered significant attention in the field of pharmaceutical research and development. This compound, identified by its CAS number 510725-53-8, belongs to a class of heterocyclic amines that exhibit diverse biological activities. The presence of the hydrochloride salt form enhances its solubility in aqueous solutions, making it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The structural motif of 1-(2-methylpropyl)piperazine hydrochloride features a piperazine ring substituted with an isobutyl group at the 1-position, coupled with a hydrochloride counterion. This specific arrangement imparts unique electronic and steric properties to the molecule, influencing its interactions with biological targets. The isobutyl group contributes to lipophilicity, while the piperazine core is known for its ability to form hydrogen bonds, a critical feature for binding to proteins and enzymes.

In recent years, 1-(2-methylpropyl)piperazine hydrochloride has been explored as a key building block in the design of novel therapeutic agents. Its versatility allows for modifications at multiple positions, enabling the creation of structurally diverse derivatives with tailored pharmacokinetic and pharmacodynamic profiles. Researchers have leveraged this compound in the development of drugs targeting neurological disorders, cardiovascular conditions, and infectious diseases.

One of the most compelling areas of research involving 1-(2-methylpropyl)piperazine hydrochloride is its potential application in treating neurological disorders. Piperazine derivatives are well-documented for their modulation of neurotransmitter systems, particularly dopamine and serotonin pathways. The isobutyl substitution enhances receptor binding affinity, making it a promising candidate for drugs aimed at alleviating symptoms associated with conditions such as depression, anxiety, and Parkinson’s disease. Recent preclinical studies have demonstrated that derivatives of this compound exhibit significant antidepressant and anxiolytic effects without the adverse side effects commonly observed with traditional treatments.

The pharmaceutical industry has also shown interest in 1-(2-methylpropyl)piperazine hydrochloride for its role in antiviral and anti-inflammatory drug development. The piperazine ring’s ability to interact with viral proteases and inflammatory cytokines has been exploited to design molecules that inhibit pathogenic processes. For instance, researchers have synthesized analogs of this compound that disrupt viral replication cycles by interfering with critical enzyme functions. These findings hold promise for the development of novel antiviral therapies against emerging pathogens.

Moreover, 1-(2-methylpropyl)piperazine hydrochloride has been investigated for its cardiovascular applications. The compound’s ability to modulate vascular tone and cholesterol metabolism makes it a candidate for drugs targeting hypertension and hyperlipidemia. Studies indicate that certain derivatives can enhance endothelial function, reduce oxidative stress, and promote plaque stabilization in arteries. Such effects are crucial for preventing cardiovascular complications associated with chronic conditions like atherosclerosis.

The synthetic pathways for 1-(2-methylpropyl)piperazine hydrochloride are well-established and efficient, allowing for scalable production suitable for industrial applications. The synthesis typically involves the alkylation of piperazine with isobutyl halides followed by salt formation with hydrochloric acid. Advances in catalytic methods have further optimized this process, reducing reaction times and improving yields. These improvements are essential for meeting the growing demand for high-purity intermediates in pharmaceutical manufacturing.

Quality control and analytical characterization of 1-(2-methylpropyl)piperazine hydrochloride are rigorous to ensure compliance with regulatory standards. Techniques such as high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry are employed to confirm molecular structure and assess purity. These analytical methods provide confidence in the compound’s suitability for downstream applications in drug development.

The future prospects of 1-(2-methylpropyl)piperazine hydrochloride are promising, driven by ongoing research into novel therapeutic applications. Collaborative efforts between academic institutions and pharmaceutical companies are likely to yield innovative derivatives with enhanced efficacy and safety profiles. As our understanding of biological mechanisms advances, so too will the potential uses of this versatile compound.

In conclusion, 1-(2-methylpropyl)piperazine hydrochloride (CAS No. 510725-53-8) represents a significant asset in medicinal chemistry due to its structural flexibility and biological activity. Its role as an intermediate in drug development spans across neurological, cardiovascular, and antiviral therapies underscores its importance in modern pharmaceutical research. With continued innovation in synthetic methodologies and mechanistic studies, this compound is poised to contribute further to advancements in human health.

• 50846-06-5(2-methyl-3-(4-methylpiperazin-1-yl)propan-1-amine)
• 57184-50-6(1-(2,2-Dimethylpropyl)piperazine)
• 5308-28-1(1-Isobutylpiperazine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)